Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-Time Delivery, Sustainability, and Competitive Costs
December 03, 2024
December 03, 2024
SAN ANTONIO, Texas, Dec. 3 -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services, issued the following news release on Dec. 2, 2024:
* * *
Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity, and innovative solutions, providing top-tier pharmaceutical manufacturing and supply chain management services.
* * *
. . .
* * *
Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity, and innovative solutions, providing top-tier pharmaceutical manufacturing and supply chain management services.
* * *
. . .